Scope

This training program covers the complete body of knowledge required for analytical method validation in pharmaceutical, biotechnology, and medical device industries.

Content includes:

• Regulatory framework (ICH, USP, FDA, Health Canada)
• Analytical instrument and system qualification (AISQ)
• HPLC method development with validation considerations
• All validation parameters (accuracy, precision, specificity, linearity, range, detection limit, quantitation limit, robustness, system suitability)
• Stability‑indicating method development and validation
• Dissolution procedure validation
• Bioanalytical method validation
• Cleaning validation
• Peptide mapping validation
• Impurity method validation
• Method transfer
• Out‑of‑specification (OOS) investigations
• Specification setting
• Implementation of new technology

The training also introduces the analytical procedure lifecycle approach described in ICH Q14 and USP ⟨1220⟩.

Objective

Learners will be able to:

• Interpret and apply ICH Q2(R2), ICH Q14, USP ⟨1225⟩ (proposed revision), USP ⟨621⟩ (revised), USP ⟨1058⟩ (draft AISQ), and relevant FDA guidance.
• Design validation protocols with scientifically justified acceptance criteria.
• Execute validation experiments for each parameter.
• Evaluate data using appropriate statistics.
• Prepare validation reports.
• Verify compendial methods.
• Transfer methods between laboratories.
• Troubleshoot validation failures.

Target Audience

• Analytical chemists
• Quality control analysts
• Quality assurance reviewers
• Validation engineers
• Laboratory managers
• Regulatory affairs specialists
• Technical staff responsible for method development, validation, or routine testing in GMP/GLP environments

Applicable Standards and Guidelines

The following official documents form the regulatory and technical basis for this training program.